Lv4
412 积分 2025-11-23 加入
MiR‐600 mediates EZH2/RUNX3 signal axis to modulate breast cancer cell viability and sorafenib sensitivity
7天前
已完结
Treatment and prognosis of patients with hormone receptor-low positive (1%-10%) breast cancer: a retrospective propensity score-matched analysis
24天前
已完结
Quantitative Evaluation of Liver perfusion Dynamics with Technetium-99m Phytate: A Peripheral IV Approach to Pre- and Post-TIPS Analysis
24天前
已关闭
c-Myc knockdown restores tamoxifen sensitivity in triple-negative breast cancer by reactivating the expression of ERα: the central role of miR-152 and miR-148a
24天前
已完结
FOXO4 suppresses cisplatin resistance of triple-negative breast cancer by inhibiting autophagy
24天前
已完结
MiR‐600 mediates EZH2/RUNX3 signal axis to modulate breast cancer cell viability and sorafenib sensitivity
24天前
已完结
Nomogram Based on the Dynamic Change in the Neutrophil-to-Lymphocyte Ratio for Predicting the Pathological Complete Response of Breast Cancer after Neoadjuvant Systemic Therapy
1个月前
已完结
Pretreatment platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as a predictor of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: single center experience from Turkey
1个月前
已完结
The predictive value of systemic immune-inflammatory markers before and after treatment for pathological complete response in patients undergoing neoadjuvant therapy for breast cancer: a retrospective study of 1994 patients
1个月前
已完结
The Neutrophil-to-Lymphocyte Ratio May be the Best Serological Biomarker in Predicting Longer Survival in Neoadjuvant Treatment of Triple-Negative Breast Cancer
1个月前
已完结
皖公网安备34019202002308
